Advertisement

Current Pain and Headache Reports

, Volume 15, Issue 2, pp 129–136 | Cite as

Opioid-Induced Hyperalgesia: Clinically Relevant or Extraneous Research Phenomenon?

  • D. Andrew Tompkins
  • Claudia M. Campbell
Article

Abstract

Opioids have become the unequivocal therapy of choice in treating many varieties of chronic pain. With the increased prescription of opioids, some unintended consequences have occurred. After prolonged opioid exposure, opioid-induced hyperalgesia (OIH), the paradoxical effect that opioid therapy may in fact enhance or aggravate preexisting pain, may occur. Over the past several decades, an increasing number of laboratory and clinical reports have suggested lowered pain thresholds and heightened atypical pain unrelated to the original perceived pain sensations as hallmarks of OIH. However, not all evidence supports the clinical importance of OIH, and some question whether the phenomenon exists at all. Here, we present a nonexhaustive, brief review of the recent literature. OIH will be reviewed in terms of preclinical and clinical evidence for and against its existence; recommendations for clinical evaluation and intervention also will be discussed.

Keywords

Opioid-induced hyperalgesia Pain hypersensitivity Opioid dependence Chronic pain Individual differences Quantitative sensory testing 

Notes

Disclosures

Dr. D. Andrew Tompkins has received a grant from the National Institute of Drug Abuse. Dr. Claudia Campbell has received travel expense compensation from Arcion Therapeutics, Inc.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Mendelson J, Flower K, Pletcher MJ, and Galloway GP: Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine. Exp.Clin.Psychopharmacol. 2008, 16:435–441.PubMedCrossRefGoogle Scholar
  2. 2.
    Andrews HL: The effect of opiates on the pain threshold in post-addicts. J.Clin.Invest 1943, 22:511–516.PubMedCrossRefGoogle Scholar
  3. 3.
    •• Fishbain DA, Cole B, Lewis JE et al.: Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Med. 2009, 10:829–839. This is a comprehensive review on human studies in opioid-induced hyperalgesia. The authors conclude that the strength of the evidence for opioid-induced hyperalgesia is limited but did not refute its existence.PubMedCrossRefGoogle Scholar
  4. 4.
    Kayan S, Woods LA, and Mitchell CL: Morphine-induced hyperalgesia in rats tested on the hot plate. J.Pharmacol.Exp.Ther. 1971, 177:509–513.PubMedGoogle Scholar
  5. 5.
    Celerier E, Laulin JP, Corcuff JB et al.: Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. J.Neurosci. 2001, 21:4074–4080.PubMedGoogle Scholar
  6. 6.
    Laulin JP, Celerier E, Larcher A et al.: Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity. Neuroscience 1999, 89:631–636.PubMedCrossRefGoogle Scholar
  7. 7.
    White F and Wilson N: Opiate-induced hypernociception and chemokine receptors. Neuropharmacology 2010, 58:35–37.Google Scholar
  8. 8.
    Minville V, Fourcade O, Girolami JP, and Tack I: Opioid-induced hyperalgesia in a mice model of orthopaedic pain: preventive effect of ketamine. Br.J.Anaesth. 2010, 104:231–238.PubMedCrossRefGoogle Scholar
  9. 9.
    Mert T, Gunes Y, Ozcengiz D, and Gunay I: Magnesium modifies fentanyl-induced local antinociception and hyperalgesia. Naunyn Schmiedebergs Arch.Pharmacol. 2009, 380:415–420.PubMedCrossRefGoogle Scholar
  10. 10.
    Chen Y, Yang C, and Wang ZJ: Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia. J.Neurosci. 2010, 30:38–46.PubMedCrossRefGoogle Scholar
  11. 11.
    Hay JL, Kaboutari J, White JM et al.: Model of methadone-induced hyperalgesia in rats and effect of memantine. Eur.J.Pharmacol. 2010, 626:229–233.PubMedCrossRefGoogle Scholar
  12. 12.
    Waxman AR, Arout C, Caldwell M et al.: Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice. Neurosci.Lett. 2009, 462:68–72.PubMedCrossRefGoogle Scholar
  13. 13.
    van Dorp EL, Kest B, Kowalczyk WJ et al.: Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans. Anesthesiology 2009, 110:1356–1363.PubMedCrossRefGoogle Scholar
  14. 14.
    Vorobeychik Y, Chen L, Bush MC, and Mao J: Improved opioid analgesic effect following opioid dose reduction. Pain Med. 2008, 9:724–727.PubMedCrossRefGoogle Scholar
  15. 15.
    Guignard B, Bossard AE, Coste C et al.: Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 2000, 93:409–417.PubMedCrossRefGoogle Scholar
  16. 16.
    Compton P, Charuvastra VC, and Ling W: Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug Alcohol Depend. 2001, 63:139–146.PubMedCrossRefGoogle Scholar
  17. 17.
    Compton P, Charuvastra VC, Kintaudi K, and Ling W: Pain responses in methadone-maintained opioid abusers. J.Pain Symptom.Manage. 2000, 20:237–245.PubMedCrossRefGoogle Scholar
  18. 18.
    • Compton P, Kehoe P, Sinha K et al.: Gabapentin improves cold-pressor pain responses in methadone-maintained patients. Drug Alcohol Depend. 2010, 109:213–219. This report describes how one medication may improve opioid-induced hyperalgesia in stable patients on methadone.PubMedCrossRefGoogle Scholar
  19. 19.
    Ren ZY, Shi J, Epstein DH et al.: Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving. Psychopharmacology (Berl) 2009, 204:423–429.CrossRefGoogle Scholar
  20. 20.
    Wasan AD, Butler SF, Budman SH et al.: Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin. J. Pain 2009, 25:193–198.PubMedCrossRefGoogle Scholar
  21. 21.
    Chu LF, Clark DJ, and Angst MS: Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J.Pain 2006, 7:43–48.PubMedCrossRefGoogle Scholar
  22. 22.
    Chen L, Malarick C, Seefeld L et al.: Altered quantitative sensory testing outcome in subjects with opioid therapy. Pain 2009, 143:65–70.PubMedCrossRefGoogle Scholar
  23. 23.
    Reznikov I, Pud D, and Eisenberg E: Oral opioid administration and hyperalgesia in patients with cancer or chronic nonmalignant pain. Br.J.Clin.Pharmacol. 2005, 60:311–318.PubMedCrossRefGoogle Scholar
  24. 24.
    Cortinez LI, Brandes V, Munoz HR et al.: No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia. Br.J.Anaesth. 2001, 87:866–869.PubMedCrossRefGoogle Scholar
  25. 25.
    Baron MJ and McDonald PW: Significant pain reduction in chronic pain patients after detoxification from high-dose opioids. J.Opioid.Manag. 2006, 2:277–282.PubMedGoogle Scholar
  26. 26.
    Koppert W, Sittl R, Scheuber K et al.: Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology 2003, 99:152–159.PubMedCrossRefGoogle Scholar
  27. 27.
    Koppert W, Angst M, Alsheimer M et al.: Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans. Pain 2003, 106:91–99.PubMedCrossRefGoogle Scholar
  28. 28.
    Schmidt S, Bethge C, Forster MH, and Schafer M: Enhanced postoperative sensitivity to painful pressure stimulation after intraoperative high dose remifentanil in patients without significant surgical site pain. Clin. J. Pain 2007, 23:605–611.PubMedCrossRefGoogle Scholar
  29. 29.
    Hood DD, Curry R, and Eisenach JC: Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia. Anesth.Analg. 2003, 97:810–815.PubMedCrossRefGoogle Scholar
  30. 30.
    • Chu LF, Dairmont J, Zamora AK et al.: The endogenous opioid System is not involved in modulation of opioid-induced hyperalgesia. J.Pain 2010. This report provides evidence that the known opioid receptors are not needed for the development of opioid-induced hyperalgesia.Google Scholar
  31. 31.
    Fillingim RB: Individual differences in pain responses. Curr.Rheumatol.Rep. 2005, 7:342–347.PubMedCrossRefGoogle Scholar
  32. 32.
    Colvin LA and Fallon MT: Opioid-induced hyperalgesia: a clinical challenge. Br.J.Anaesth. 2010, 104:125–127.PubMedCrossRefGoogle Scholar
  33. 33.
    Bodnar RJ and Kest B: Sex differences in opioid analgesia, hyperalgesia, tolerance and withdrawal: central mechanisms of action and roles of gonadal hormones. Horm.Behav. 2010, 58:72–81.PubMedCrossRefGoogle Scholar
  34. 34.
    Holtman JR, Jr. and Wala EP: Characterization of morphine-induced hyperalgesia in male and female rats. Pain 2005, 114:62–70.PubMedCrossRefGoogle Scholar
  35. 35.
    Juni A, Klein G, Kowalczyk B et al.: Sex differences in hyperalgesia during morphine infusion: effect of gonadectomy and estrogen treatment. Neuropharmacology 2008, 54:1264–1270.PubMedCrossRefGoogle Scholar
  36. 36.
    Kavaliers M and Choleris E: Sex differences in N-methyl-D-aspartate involvement in kappa opioid and non-opioid predator-induced analgesia in mice. Brain Res. 1997, 768:30–36.PubMedCrossRefGoogle Scholar
  37. 37.
    Juni A, Cai M, Stankova M et al.: Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor. Anesthesiology 2010, 112:181–188.PubMedCrossRefGoogle Scholar
  38. 38.
    Ram KC, Eisenberg E, Haddad M, and Pud D: Oral opioid use alters DNIC but not cold pain perception in patients with chronic pain—new perspective of opioid-induced hyperalgesia. Pain 2008, 139:431–438.PubMedCrossRefGoogle Scholar
  39. 39.
    Jensen KB, Lonsdorf TB, Schalling M et al.: Increased sensitivity to thermal pain following a single opiate dose is influenced by the COMT val(158)met polymorphism. PLoS.One. 2009, 4:e6016.PubMedCrossRefGoogle Scholar
  40. 40.
    Edwards RR, Wasan A, Jamison R. Hyperalgesia in pain patients at elevated risk for opioid misuse. J.Pain 2010, 11:S45.Google Scholar
  41. 41.
    • Chapman CR, Lipschitz DL, Angst MS et al.: Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J.Pain 2010, 11:807–829. This is a report on the specific research needs for the pain treatment field for the future.PubMedCrossRefGoogle Scholar
  42. 42.
    • Kapural L, Kapural M, Bensitel T, and Sessler DI: Opioid-sparing effect of intravenous outpatient ketamine infusions appears short-lived in chronic-pain patients with high opioid requirements. Pain Physician 2010, 13:389–394. This report provides evidence that ketamine infusions can reduce pain and opioid requirements in persons with chronic pain, but the benefits remit 6 months after ending treatment.PubMedGoogle Scholar
  43. 43.
    Angst MS and Clark JD: Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006, 104:570–87.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Psychiatry and Behavioral SciencesJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations